Background Inflammation may play an important role in cancer progression, and a high
neutrophil-to-lymphocyte ratio (NLR) has been reported to be a poor prognostic indicator in …

Background: Inflammation influences cancer development and progression. An elevated
platelet to lymphocyte ratio (PLR), a marker of inflammation, has been linked to poor …

Background & Aims Immunotherapy with atezolizumab plus bevacizumab represents the
new standard of care in systemic front-line treatment of hepatocellular carcinoma (HCC) …

Background & Aims Overall survival (OS) is a composite clinical endpoint in hepatocellular
carcinoma (HCC) due to the mutual influence of cirrhosis and active malignancy in dictating …

Since the initial work, a decade ago that the combination of C-reactive protein and albumin,
the Glasgow Prognostic Score (GPS), had independent prognostic value in patients with …

Abstract Background/Aims: Systemic inflammatory response (SIR) is widely considered as a
preoperative risk factor for hepatocellular carcinoma (HCC) outcomes. The neutrophil to …

Introduction Cancer remains a leading cause of death worldwide. While a curative intent is
the aim of any surgical treatment many patients either present with or go onto develop …

Background The C-reactive protein/albumin (CRP/Alb) ratio is associated with outcomes in
septic patients. We investigated the prognostic value of the CRP/Alb ratio in patients with …

Objectives Serous cystic neoplasm (SCN) is a cystic neoplasm of the pancreas whose
natural history is poorly known. The purpose of the study was to attempt to describe the …

Background Recently, more and more studies investigated the association of inflammation
parameters such as the Platelet Lymphocyte Ratio (PLR) and the prognosis of various …